Northern Trust’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.21M | Sell |
611,536
-29,411
| -5% | -$202K | ﹤0.01% | 2558 |
|
|
2025
Q1 | $1.85M | Sell |
640,947
-69,374
| -10% | -$200K | ﹤0.01% | 2966 |
|
|
2024
Q4 | $3.34M | Buy |
710,321
+142,578
| +25% | +$670K | ﹤0.01% | 2749 |
|
|
2024
Q3 | $2.03M | Buy |
567,743
+400,849
| +240% | +$1.43M | ﹤0.01% | 2995 |
|
|
2024
Q2 | $1.03M | Buy |
166,894
+30,461
| +22% | +$189K | ﹤0.01% | 3236 |
|
|
2024
Q1 | $1.29M | Sell |
136,433
-8,532
| -6% | -$80.5K | ﹤0.01% | 3197 |
|
|
2023
Q4 | $979K | Buy |
144,965
+1,984
| +1% | +$13.4K | ﹤0.01% | 3326 |
|
|
2023
Q3 | $635K | Sell |
142,981
-446
| -0.3% | -$1.98K | ﹤0.01% | 3446 |
|
|
2023
Q2 | $473K | Sell |
143,427
-308,525
| -68% | -$1.02M | ﹤0.01% | 3556 |
|
|
2023
Q1 | $1.29M | Buy |
451,952
+61,476
| +16% | +$175K | ﹤0.01% | 3128 |
|
|
2022
Q4 | $2.84M | Buy |
390,476
+79,183
| +25% | +$576K | ﹤0.01% | 2807 |
|
|
2022
Q3 | $2.52M | Buy |
311,293
+2,999
| +1% | +$24.3K | ﹤0.01% | 2891 |
|
|
2022
Q2 | $1.51M | Buy |
308,294
+51,368
| +20% | +$252K | ﹤0.01% | 3203 |
|
|
2022
Q1 | $6.08M | Sell |
256,926
-6,147
| -2% | -$145K | ﹤0.01% | 2468 |
|
|
2021
Q4 | $4.65M | Buy |
263,073
+5,201
| +2% | +$92K | ﹤0.01% | 2722 |
|
|
2021
Q3 | $7.28M | Buy |
257,872
+40,161
| +18% | +$1.13M | ﹤0.01% | 2498 |
|
|
2021
Q2 | $2.28M | Buy |
217,711
+20,503
| +10% | +$215K | ﹤0.01% | 3295 |
|
|
2021
Q1 | $2.32M | Buy |
197,208
+7,199
| +4% | +$84.8K | ﹤0.01% | 3157 |
|
|
2020
Q4 | $2.23M | Buy |
190,009
+11,840
| +7% | +$139K | ﹤0.01% | 3148 |
|
|
2020
Q3 | $1.41M | Buy |
178,169
+10,696
| +6% | +$84.8K | ﹤0.01% | 3223 |
|
|
2020
Q2 | $3.06M | Buy |
167,473
+33,188
| +25% | +$607K | ﹤0.01% | 2806 |
|
|
2020
Q1 | $1.6M | Buy |
134,285
+83,233
| +163% | +$994K | ﹤0.01% | 2981 |
|
|
2019
Q4 | $849K | Sell |
51,052
-2,159
| -4% | -$35.9K | ﹤0.01% | 3442 |
|
|
2019
Q3 | $353K | Buy |
+53,211
| New | +$353K | ﹤0.01% | 3622 |
|